公开(公告)号：US6143332A

公开(公告)日：2000-11-07

申请号：US431724

申请日：1999-11-01

申请人： Linsey McLean

发明人： Linsey McLean

IPC分类号： A61K33/10 ,  A61K33/08 ,  A61K31/195 ,  A61K31/315 ,  A61K33/00

CPC分类号： A61K33/10

摘要： A nutritional supplement for the prevention and treatment of excessive intestinal permeability is provided. The treatment includes a dietary regimen of nutritional buffers, amino acid chelates, minerals and vitamins. Other components may include antioxidants, free radical scavengers, beneficial organisms, and intestinal tract-soothing herbs.

摘要翻译： 提供了用于预防和治疗过度肠通透性的营养补充剂。 治疗包括营养缓冲液，氨基酸螯合物，矿物质和维生素的饮食方案。 其它组分可包括抗氧化剂，自由基清除剂，有益生物和肠道舒缓草药。

公开(公告)号：US5976579A

公开(公告)日：1999-11-02

申请号：US887909

申请日：1997-07-03

申请人： Linsey McLean

发明人： Linsey McLean

IPC分类号： A61K33/10 ,  A61K33/08 ,  A61K31/195 ,  A61K31/315 ,  A61K33/00

CPC分类号： A61K33/10

摘要： A nutritional supplement for the prevention and treatment of excessive intestinal permeability is provided. The treatment includes a dietary regimen of nutritional buffers, amino acid chelates, minerals and vitamins. Other components may include antioxidants, free radical scavengers, beneficial organisms, and intestinal tract-soothing herbs.

公开(公告)号：US20180136238A1

公开(公告)日：2018-05-17

申请号：US15699293

申请日：2017-09-08

申请人： Linsey McLean

发明人： Linsey McLean

IPC分类号： G01N33/74 ,  G01N33/20 ,  G16H50/30

CPC分类号： G01N33/743 ,  G01N33/20 ,  G01N2333/70596 ,  G16H10/40 ,  G16H50/30

摘要： Currently, the analysis of metals for toxicity evaluation are only assayed for total quantity/quantitative elemental analysis, and no assessment to date evaluates the individual toxicities and sum total toxicities of the individual chemical forms of metals, which can be radically different. A better assessment of true toxicity can be made by looking at the quantitative numbers of each of the chemical forms the metal exists in as a function of one of the different valuations of toxicity, such as LD50 numbers, LD0, LD100, LC50, LOAEL, NOAEL, PEL, REL, TLV, etc., for a new terminology of Toxic Relevance Number (TRN), and the sum of TRN's for the individual chemical forms as TTRN, Total Toxic Relevance Number. While LD 50 is preferred, any of these valuations can be used in the same model to advance our understanding and assessment of true toxicity of a certain metal in a specific exposure.

公开(公告)号：US5958462A

公开(公告)日：1999-09-28

申请号：US862683

申请日：1997-05-23

申请人： Linsey McLean

发明人： Linsey McLean

IPC分类号： A61K8/19 ,  A61K8/20 ,  A61K8/23 ,  A61K8/92 ,  A61Q13/00 ,  A61Q19/10 ,  A01N59/20 ,  A01N59/00 ,  A01N59/06 ,  A01N59/08

CPC分类号： A61K8/23 ,  A61K8/19 ,  A61K8/20 ,  A61K8/922 ,  A61Q13/00 ,  A61Q19/10 ,  Y10S514/886 ,  Y10S514/906

摘要： Therapeutic bath salts for the relaxation of muscles, elimination or reduction of muscle spasms, and for the overall enhancement of a person's mood. The bath salts of the present invention are used as aromatherapy that has both the convenience of a bath and the internal mechanisms of ingested medication. The formula for the composition of the present invention includes a selected amount of magnesium sulfate trihydrate (a hydrated version of epsom salts), lithium chloride, copper gluconate, and essential oils. The oils include rosewood oil, ylang ylang oil, lavender oil and patchouli oil. The oils are provided as scents for use in the prescribed aromatherapy. The user mixes a preselected amount of the crystallized salt or liquid form of the present invention with the bath water. A period of time is allowed to elapse before the user departs the bath. By resting in the tub, the user accrues the combined benefits of external therapy and internal therapy.

摘要翻译： 用于放松肌肉，消除或减少肌肉痉挛的治疗浴盐，以及整体提高人的心情。 本发明的沐浴盐被用作具有浴的便利性和吸食药物的内部机制的芳香疗法。 本发明组合物的配方包括选择量的硫酸镁三水合物（epsom盐的水合形式），氯化锂，葡萄糖酸铜和精油。 油包括红木油，依兰油，薰衣草油和广藿香油。 这些油被提供为用于规定的芳香疗法中的香味。 用户将预选量的本发明的结晶盐或液体形式与浴水混合。 在用户离开浴室之前，允许一段时间过去。 通过在浴缸中休息，用户可以获得外部治疗和内部治疗的综合益处。

公开(公告)号：US5935610A

公开(公告)日：1999-08-10

申请号：US612022

申请日：1996-03-05

申请人： Linsey McLean

发明人： Linsey McLean

IPC分类号： A23L1/302 ,  A23L1/304 ,  A61K9/00 ,  A61K33/10 ,  A61K45/06 ,  A61K47/00 ,  A61K47/02 ,  A61K47/12 ,  A61K33/32 ,  A61K33/08

CPC分类号： A61K33/10 ,  A23L33/15 ,  A23L33/16 ,  A61K45/06 ,  A61K9/0095 ,  A23V2002/00 ,  A61K47/02 ,  A61K47/12

摘要： A pharmaceutical composition having buffering properties comprises as its primary ingredients calcium carbonate (CaCO.sub.3) and magnesium oxide (MgO; magnesia) that form the base for the compound. Potassium sorbate (CH.sub.3 CH: CHCH:CHCOOK) is provided as a preservative. Other ingredients include a tabletizing binder, vitamin complexes, minerals as antipathogens, and flavorings.

摘要翻译： 具有缓冲性质的药物组合物作为其主要成分包括形成化合物的碱的碳酸钙（CaCO 3）和氧化镁（MgO;氧化镁）。 提供山梨酸钾（CH 3 CH:CHCH:CHCOOK）作为防腐剂。 其他成分包括压片粘合剂，维生素复合物，矿物质作为抗病原体和调味剂。

公开(公告)号：US5855949A

公开(公告)日：1999-01-05

申请号：US586263

申请日：1996-01-16

申请人： Linsey McLean

发明人： Linsey McLean

IPC分类号： A23L1/29 ,  A23L1/30 ,  A23L1/302 ,  A23L1/304 ,  A23D9/00

CPC分类号： A23L33/16 ,  A23L33/10 ,  A23L33/115 ,  A23L33/15 ,  A23L33/30 ,  A23L33/40 ,  A23V2002/00

摘要： A dietary system for the treatment of obesity, for the lowering of saturated fats in the blood and, in a modified form, for stimulation of the sympathetic nervous system and general basal metabolism. The system includes a diet that restricts the patient to the intake of certain foods in certain amounts and combines this intake with specific supplements. The supplements include prescribed amounts of vitamins, minerals, and oils. The oils are selected from that group that are high in essential fatty acids such as olive oil and canola oil. The prescribed foods comprise low fat, low carbohydrate, moderate protein foods. By providing the patient with a diet high in essential fatty acids, the glucagon-driven pathway of the patient is stimulated and less fat is stored by the body. In addition, more body fat is catalyzed for the production of energy for use by the body. In its modified form, the diet includes a daily regimen of various hormones including DHEA, progesterone, testosterone, and desiccated thyroid.

摘要翻译： 一种用于治疗肥胖的饮食系统，用于降低血液中的饱和脂肪，并且以改性形式降低刺激交感神经系统和一般基础代谢。 该系统包括饮食，其将患者限制在某些食物的摄入量中，并将该摄取物与特定的补充剂组合。 补品包括规定量的维生素，矿物质和油类。 这些油选自高必需脂肪酸如橄榄油和菜籽油的组。 规定的食物包括低脂肪，低碳水化合物，中等蛋白质食物。 通过为患者提供高必需脂肪酸的饮食，刺激患者的胰高血糖素驱动的途径，并且较少的脂肪被身体储存。 此外，更多的身体脂肪被催化用于生产用于身体的能量。 在改良形式中，饮食包括各种激素的日常养生方式，包括DHEA，孕激素，睾丸激素和干燥的甲状腺。

公开(公告)号：US5496567A

公开(公告)日：1996-03-05

申请号：US112768

申请日：1993-08-26

申请人： Linsey McLean

发明人： Linsey McLean

IPC分类号： A23L1/302 ,  A23L1/304 ,  A61K9/00 ,  A61K33/10 ,  A61K45/06 ,  A61K47/00 ,  A61K47/02 ,  A61K47/12 ,  A61K33/08 ,  A61K31/195 ,  A61K31/315 ,  A61K33/00

CPC分类号： A61K33/10 ,  A23L33/15 ,  A23L33/16 ,  A61K45/06 ,  A61K9/0095 ,  A23V2002/00 ,  A61K47/02 ,  A61K47/12

摘要： A liquid pharmaceutical composition having buffering properties comprises as its primary ingredients calcium carbonate (CaCO.sub.3) and magnesium oxide (MgO; magnesia) or magnesium hydroxide (Mg(OH).sub.2) that form the base for the compound. The base is carried in a suspension of oil and water. Lecithin (CH.sub.2 (R)CH(R')CH.sub.2 OPO(OH))(CH.sub.2).sub.2 N(OH)(CH.sub.2).sub.3 is provided as an emulsifier and potassium sorbate (CH.sub.3 CH: CHCH:CHCOOK) is provided as a preservative. Other ingredients include vitamin complexes, selected metal chelates as antipathogens, and flavorings.

摘要翻译： 具有缓冲性质的液体药物组合物作为其主要成分包括形成化合物的碱的碳酸钙（CaCO 3）和氧化镁（MgO;氧化镁）或氢氧化镁（Mg（OH）2）。 底座被装在油和水的悬浮液中。 提供卵磷脂（CH 2（R）CH（R'）CH 2 OPO（OH））（CH 2）2 N（OH）（CH 2）3作为乳化剂，并且提供山梨酸钾（CH 3 CH:CHCH:CHCOOK）作为防腐剂。 其他成分包括维生素配合物，选择的金属螯合物作为抗病原体和调味剂。

公开(公告)号：US5484623A

公开(公告)日：1996-01-16

申请号：US179188

申请日：1994-01-10

申请人： Linsey McLean

发明人： Linsey McLean

IPC分类号： A23L1/29 ,  A23L1/30 ,  A23L1/302 ,  A23L1/304 ,  A23D9/00

CPC分类号： A23L33/16 ,  A23L33/10 ,  A23L33/115 ,  A23L33/15 ,  A23L33/30 ,  A23L33/40 ,  A23V2002/00

摘要： A dietary system for the treatment of obesity and for the lowering of saturated fats in the blood. The system includes a diet that restricts the patient to the intake of certain foods in certain amounts and combines this intake with specific supplements. The prescribed foods comprise those low in saturated fats and carbohydrates, those having moderate amounts of proteins, and oils high in monounsaturates and certain fatty acids such as olive oil and canola oil. The supplements include prescribed amounts of vitamins and minerals. By providing the patient with a diet high in essential fatty acids, the glucagon-driven pathway of the patient is stimulated and less fat is stored by the body. In addition, more body fat is catalyzed for the production of energy for use by the body.

摘要翻译： 用于治疗肥胖和降低血液中饱和脂肪的饮食系统。 该系统包括饮食，其将患者限制在一定量的某些食物的摄入中，并将该摄取物与特定的补充剂组合。 规定的食物包括那些低饱和脂肪和碳水化合物，具有中等量蛋白质的食物，以及单不饱和脂肪酸和某些脂肪酸如橄榄油和菜籽油的油。 补品包括规定量的维生素和矿物质。 通过为患者提供高必需脂肪酸的饮食，刺激患者的胰高血糖素驱动的途径，并且较少的脂肪被身体储存。 此外，更多的身体脂肪被催化用于生产用于身体的能量。